tiprankstipranks
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
US Market
Holding GYRE?
Track your performance easily

Gyre Therapeutics (GYRE) Technical Analysis

799 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
3Neutral
9Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Gyre Therapeutics’s (GYRE) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Gyre Therapeutics is a Sell.
Gyre Therapeutics’s (GYRE) 20-Day exponential moving average is 11.06, while Gyre Therapeutics’s (GYRE) share price is $11.48, making it a Buy.
Gyre Therapeutics’s (GYRE) 50-Day exponential moving average is 11.49, while Gyre Therapeutics’s (GYRE) share price is $11.48, making it a Sell.

Gyre Therapeutics (GYRE) Pivot Points

Jan 30, 2025, 11:25 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.74
10.95
11.35
11.56
11.96
12.17
12.57
Fibonacci
10.95
11.19
11.33
11.56
11.80
11.94
12.17
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Gyre Therapeutics (GYRE) Moving Averages

Jan 30, 2025, 11:25 PM
Period
Simple
Exponential
MA5
11.28Buy
11.34Buy
MA10
11.07Buy
11.14Buy
MA20
10.91Buy
11.06Buy
MA50
11.27Buy
11.49Sell
MA100
12.52Sell
12.14Sell
MA200
12.77Sell
13.00Sell
Gyre Therapeutics’s (GYRE) 10-Day exponential moving average is 11.14, while Gyre Therapeutics’s (GYRE) share price is $11.48, making it a Buy.
Gyre Therapeutics’s (GYRE) 100-Day exponential moving average is 12.14, while Gyre Therapeutics’s (GYRE) share price is $11.48, making it a Sell.
Gyre Therapeutics’s (GYRE) stock price is $11.48 and Gyre Therapeutics’s (GYRE) 50-day simple moving average is 11.27, creating a Buy signal.
Gyre Therapeutics’s (GYRE) stock price is $11.48 and Gyre Therapeutics’s (GYRE) 100-day simple moving average is 12.52, creating a Sell signal.
Gyre Therapeutics’s (GYRE) stock price is $11.48 and Gyre Therapeutics’s (GYRE) 200-day simple moving average is 12.77, creating a Sell signal.

Gyre Therapeutics (GYRE) Technical Indicators

Jan 30, 2025, 11:25 PM
Name
Value
Implied Action
RSI (14)
53.52
Neutral
STOCH (9,6)
86.23
Sell
STOCHRSI (14)
91.08
Sell
MACD (12,26)
-0.02
Sell
ADX (14)
18.89
Buy
Williams %R
-13.22
Sell
CCI (14)
60.30
Neutral
ATR (14)
0.77
-
Ultimate Oscillator
58.84
Neutral
ROC
14.91
Buy
Gyre Therapeutics’s (GYRE) Relative Strength Index (RSI) is 53.52, creating a Neutral signal.
Gyre Therapeutics’s (GYRE) Trend Strength Indicator (ADX) is 18.89, creating a Buy signal.
Gyre Therapeutics’s (GYRE) Commodity Channel Index (CCI) is 60.30, creating a Neutral signal.
Gyre Therapeutics’s (GYRE) Price Rate of Change (ROC) is 14.91, creating a Buy signal.

FAQ

Is GYRE a Buy, Hold, or Sell?
Based on GYRE’s technical indicators, GYRE is a Hold.
    What is GYRE’s RSI (14)?
    GYRE’s RSI (14) is 53.52, which suggests GYRE is a Neutral.
      What is GYRE’s MACD?
      GYRE’s MACD is -0.02, which suggests GYRE is a Sell.
        What is GYRE’s 5-day moving average?
        GYRE’s 5-day moving average is 11.28, which suggests GYRE is a Buy.
          What is GYRE’s 20-day moving average?
          GYRE 20-day moving average is 10.91, which suggests GYRE is a Buy.
            What is GYRE’s 50-day moving average?
            GYRE’s 50-day moving average is 11.27, which suggests GYRE is a Buy.
              What is GYRE’s 200-day moving average?
              GYRE’s 200-day moving average is 12.77, which suggests GYRE is a Sell.
                What is GYRE’s Williams % R (14)?
                GYRE’s Williams % R (14) is -13.22, which suggests GYRE is a Sell.
                  What is GYRE’s CCI (14)?
                  GYRE’s CCI (14) is 60.30, which suggests GYRE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis